DAR DARLING INGREDIENTS INC.
Fats & Oils · NYSE · SEC CIK 916540 · Fiscal year ends 01/02
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.9%
TTM net income YoY684.6%
TTM EPS YoY685.1%
Revenue 3-yr CAGR-0.8%
Net income 3-yr CAGR5.5%
Margins
Gross margin26.8%
Operating margin17.9%
Net margin12.5%
FCF margin—
EBITDA margin25.8%
Returns
ROE16.8%
ROA8.0%
ROIC (approx.)11.2%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets49.2%
Debt / equity0.65x
Current ratio1.42x
Interest coverage5.60x
Cash quality & payout
Operating cash flow / net income1.88x
Accruals ratio-7.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252026-01-03 | FY20242024-12-28 |
|---|---|---|
| Income statement | ||
| Revenue | $6.14B | $5.72B |
| Cost of revenue | $4.66B | $4.44B |
| Gross profit | $1.47B | $1.28B |
| SG&A expense | $551.16M | $492.11M |
| Operating income | $273.44M | $468.22M |
| Interest expense | $222.28M | $253.86M |
| Pretax income | $61.03M | $247.51M |
| Income tax | -$9.36M | -$38.34M |
| Net income | $62.80M | $278.88M |
| EBITDA | $781.94M | $972.04M |
| EPS (basic) | 0.40 | 1.75 |
| EPS (diluted) | 0.39 | 1.73 |
| Weighted avg. shares (diluted) | 160.16M | 161.42M |
| Balance sheet | ||
| Cash & equivalents | $88.67M | $217.31M |
| Inventory | $527.74M | $576.84M |
| Current assets | $1.55B | $1.44B |
| PP&E, net | $2.80B | $2.71B |
| Goodwill | $2.46B | $2.32B |
| Intangibles | $845.00M | $898.41M |
| Total assets | $10.30B | $10.07B |
| Current liabilities | $1.03B | $1.04B |
| Short-term debt | $75.22M | $133.02M |
| Long-term debt | $3.86B | $3.91B |
| Total debt | $3.94B | $4.04B |
| Total liabilities | $5.49B | $5.61B |
| Shareholders' equity | $4.74B | $4.38B |
| Net debt | $3.85B | $3.82B |
| Cash flow statement | ||
| Operating cash flow | $1.06B | $839.29M |
| Capital expenditure | $380.48M | $332.46M |
| Free cash flow | $679.24M | $506.82M |
| Investing cash flow | -$681.45M | -$498.90M |
| Financing cash flow | -$376.73M | -$399.56M |
| Depreciation & amortization | $508.50M | $503.82M |
| Stock-based compensation | $21.80M | $20.92M |
| Share buybacks | $34.67M | $34.27M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.